Home > Search Results
  • Added to PubMed Health

    • Custom range...

Results: 6

Effectiveness and safety of progabide for refractory epilepsy: a meta-analysis

Bibliographic details: Yuan TT, Wu B, Zou XY.  Effectiveness and safety of progabide for refractory epilepsy: a meta-analysis. Chinese Journal of Evidence-Based Medicine 2012; 12(7): 810-816 Available from: http://www.cjebm.org.cn/oa/DArticle.aspx?type=view&id=2012070013

Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews [Internet] - Centre for Reviews and Dissemination (UK).

Version: 2012

Dementia: A NICE-SCIE Guideline on Supporting People With Dementia and Their Carers in Health and Social Care

This guideline has been developed to advise on supporting people with dementia and their carers in health and social care. The guideline recommendations have been developed by a multidisciplinary team of health and social care professionals, a person with dementia, carers and guideline methodologists after careful consideration of the best available evidence. It is intended that the guideline will be useful to practitioners and service commissioners in providing and planning high-quality care for those with dementia while also emphasising the importance of the experience of care for people with dementia and carers.

NICE Clinical Guidelines - National Collaborating Centre for Mental Health (UK).

Version: 2007
Show search results within this document

Gamma‐aminobutyric acid agonists for neuroleptic‐induced tardive dyskinesia

Having to take antipsychotic drugs for long periods of time can cause repetitive movements ‐ often of the face and mouth. These are disfiguring and do not necessarily cease once medication is reduced or changed. Gamma‐aminobutyric acid agonists have been evaluated for treating these movement disorders, but, so far, the benefit of this medication seems small and restricted to avoidance of deterioration.

Cochrane Database of Systematic Reviews: Plain Language Summaries [Internet] - John Wiley & Sons, Ltd.

Version: 2012

Drug Class Review: Skeletal Muscle Relaxants: Final Report [Internet]

Skeletal muscle relaxants are a heterogeneous group of medications commonly used to treat two different types of underlying conditions: spasticity from upper motor neuron syndromes and muscular pain or spasms from peripheral musculoskeletal conditions. The purpose of this report is to determine whether there is evidence that one or more skeletal muscle relaxant is superior to others in terms of efficacy or safety.

Drug Class Reviews - Oregon Health & Science University.

Version: May 2005
Show search results within this document

Stiripentol (Diacomit): For Severe Myoclonic Epilepsy in Infancy (Dravet Syndrome) [Internet]

The objective of this review was to perform a systematic review of the beneficial and harmful effects of stiripentol 250 mg and 500 mg as adjunctive therapy for refractory generalized tonic-clonic seizures in patients with severe myoclonic epilepsy in infancy (SMEI, Dravet syndrome).

Common Drug Review - Canadian Agency for Drugs and Technologies in Health.

Version: April 2015
Show search results within this document

Motor Neurone Disease: Assessment and Management

Motor neurone disease (MND) is a neurodegenerative condition that affects the brain and spinal cord. MND is characterised by the degeneration of primarily motor neurones, leading to muscle weakness.

NICE Guideline - National Clinical Guideline Centre (UK).

Version: February 2016
Show search results within this document

Systematic Reviews in PubMed

See all (8)...

Systematic Review Methods in PubMed

See all (2)...

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...